Publication:
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

dc.contributor.authorChioncel, Ovidiu (12769077100)
dc.contributor.authorMebazaa, Alexandre (57210091243)
dc.contributor.authorHarjola, Veli-Pekka (6602728533)
dc.contributor.authorCoats, Andrew J. (35395386900)
dc.contributor.authorPiepoli, Massimo Francesco (7005292730)
dc.contributor.authorCrespo-Leiro, Maria G. (35401291200)
dc.contributor.authorLaroche, Cecile (7102361087)
dc.contributor.authorSeferovic, Petar M. (6603594879)
dc.contributor.authorAnker, Stefan D. (56223993400)
dc.contributor.authorFerrari, Roberto (36047514600)
dc.contributor.authorRuschitzka, Frank (7003359126)
dc.contributor.authorLopez-Fernandez, Silvia (55604539700)
dc.contributor.authorMiani, Daniela (6602718496)
dc.contributor.authorFilippatos, Gerasimos (7003787662)
dc.contributor.authorMaggioni, Aldo P. (57203255222)
dc.date.accessioned2025-06-12T17:01:12Z
dc.date.available2025-06-12T17:01:12Z
dc.date.issued2017
dc.description.abstractAims: To identify differences in clinical epidemiology, in-hospital management and 1-year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long-Term (ESC-HF-LT) Registry, stratified by clinical profile at admission. Methods and results: The ESC-HF-LT Registry is a prospective, observational study collecting hospitalization and 1-year follow-up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.2% presented with pulmonary oedema (PO), 2.9% with cardiogenic shock (CS), 61.1% with decompensated heart failure (DHF), 4.8% with hypertensive heart failure (HT-HF), 3.5% with right heart failure (RHF) and 14.4% with AHF and associated acute coronary syndromes (ACS-HF). The 1-year mortality rate was 28.1% in PO, 54.0% in CS, 27.2% in DHF, 12.8% in HT-HF, 34.0% in RHF and 20.6% in ACS-HF patients. When patients were classified by systolic blood pressure (SBP) at initial presentation, 1-year mortality was 34.8% in patients with SBP <85 mmHg, 29.0% in those with SBP 85–110 mmHg, 21.2% in patients with SBP 110–140 mmHg and 17.4% in those with SBP >140 mmHg. These differences tended to diminish in the months post-discharge, and 1-year mortality for the patients who survived at least 6 months post-discharge did not vary significantly by either clinical profile or SBP classification. Conclusion: Rates of adverse outcomes in AHF remain high, and substantial differences have been found when patients were stratified by clinical profile or SBP. However, patients who survived at least 6 months post-discharge represent a more homogeneous group and their 1-year outcome is less influenced by clinical profile or SBP at admission. © 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology
dc.identifier.urihttps://doi.org/10.1002/ejhf.890
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85018783513&doi=10.1002%2fejhf.890&partnerID=40&md5=9eb16e816a7e0d5499f1a748764fc656
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/6767
dc.subjectAcute heart failure
dc.subjectClinical profile
dc.subjectOutcomes
dc.titleClinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry
dspace.entity.typePublication

Files